Renaissance Technologies
KYTH

Renaissance Technologies’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Renaissance Technologies’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-116,400
Closed -$4.63M – 3142
2014
Q1 		$4.63M Buy
116,400
+75,200
+183% +$3.36M 0.01% 1300
2013
Q4 		$1.54M Buy
+41,200
New +$1.71M ﹤0.01% 1878

Other funds holding KYTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Renaissance Technologies's KYTH Position: Q2 2014 in Review

Renaissance Technologies sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q2 2014, closing a stake of 116,400 shares — an estimated $4.63M sold.

Renaissance Technologies first reported a position in KYTH in Q4 2013 and held it in 2 quarters. The position peaked at $4.63M in Q1 2014. 104 funds tracked by Wall St. Rank hold KYTH as of Q2 2014.

  • Renaissance Technologies reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q2 2014 after selling out during the quarter.
  • Renaissance Technologies sold 116,400 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q2 2014, an estimated $4.63M.
  • Renaissance Technologies first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q4 2013 and held it in 2 quarters.
  • Renaissance Technologies's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $4.63M in Q1 2014.
  • 104 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q2 2014.

Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.